Vol. 07 • Na. 1 • March 2005

In this issue:

• Buprenorphine induction and stabilisation in the treatment of opiate dependence
  Doran C., Holmes J., Ladewig D., Ling W.
• Clinical significance of electroencephalographic abnormalities in heroin addicts: Systematic review
  Polunina A. G., Davydov D. M., Briun E. A.
• Alcohol abuse in heroin addicts: An unfolding metabolic destiny
  Pacini M., Mellini A., Attilia M. L., Ceccanti M., Maremmani I.
• Symptomatic treatment of opiate withdrawal syndrome by low-dose buprenorphine in an in-patient setting
  Fuscone A., Correale M., Romualdo M., Bianchi W.
• Open letter to physicians and other health care providers facing pain management during opioid agonist therapy with methadone
  Payte J. T.

Vol. 07 • Na. 2 • June 2005

In this issue:

• Methadone maintenance treatment and mood disturbances: Pharmacological and psychological implications
  Dyer K. R.
• Long-term treatment for patients with severe mental illness and substance abuse
  Blix O., Eek U.
• Good practice, good results. Maintenance treatment outcomes in France
  Coppel A.
• The endogenous cannabinoid system: Physiological modulation of neuronal activity
  Marsicano G.
• Substitution treatment in European prisons. A study of policies and practices of substitution treatment in prison in 18 European countries
  Hennebel L. C., Stöver
• Medical meaning of psychosocial issues of heroin addiction
  Pacini M., Maremmani I.

Vol. 07 • Na. 3 • September 2005

In this issue:

• Psychotherapy for patients in methadone treatment
  Bignamini E., Zazza S.
• Buprenorphine high-dose, broad spectrum, long-term treatment: A new clinical approach to opiate alkaloid dependency
  Di Petta G., Leonardi C.
• Correlation between high methadone dose and methadone blood level in methadone maintenance treatment patients
  Peles E., Bodner G., Adelson M.
• Addictive disorders, bipolar spectrum and the impulsive link: The psychopathology of a self-regenerating pathway
  Maremmani I., Pacini M., Perugi G.
• Bridging the preclinical - clinical gap
  Nutt D. J., Lingford-Hughes A., Daglish M., Williams T., Taylor L., Wilson S., Davies S., Melichar J., Myles J.
• Mortality and retention of drug users in GP Shared Care in Glasgow
  Gilhooly T.
• Working with the patient for optimal treatment outcomes in UK General Practice
  Ford C., Oliver J., Whitehead B.

Vol. 07 • Na. 4 • December 2005

In this issue:

• Addiction and Pregnancy
  Finnegan L., Amass L., Jones H., Kaltenbach K.
• Primary care physicians and addiction treatment in Germany. Decentralization and take-home policy
  Ulmer A.
• Psychopathological disorders in heroin addicts and administration of risperidone during rehabilitation
  Kozlov A. A., Dorovskih I. V., Doljanskaia N. A., Buzina T. S., Polunina A. G.
• Methadone reduces the need for antipsychotic and antimanic agents in heroin addicts hospitalized for manic and/or acute psychotic episodes
  Pacini M., Maremmani I.
• Methadone serum concentration and its relationship to methadone dose revisited
  Okruhlica L., Valentova J., Devinsky F., Formakova S., Klempova D.
• Medical and social factors determining early poly-drug dependence
  Chernobrovkina T. V., Igor A. Nikiforov I. A.